KISUNLA Trademark

Trademark Overview

On Tuesday, June 8, 2021, a trademark application was filed for KISUNLA with the United States Patent and Trademark Office. The USPTO has given the KISUNLA trademark a serial number of 90761518. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Wednesday, August 7, 2024. This trademark is owned by Eli Lilly and Company. The KISUNLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, central nervous system diseases and disorders, dementia, mental disorders, neurodegenerative diseases and disorders, and neurological disorders
kisunla

General Information

Serial Number90761518
Word MarkKISUNLA
Filing DateTuesday, June 8, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateWednesday, August 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, central nervous system diseases and disorders, dementia, mental disorders, neurodegenerative diseases and disorders, and neurological disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, August 29, 2021
Primary Code005
First Use Anywhere DateWednesday, July 31, 2024
First Use In Commerce DateWednesday, July 31, 2024

Trademark Owner History

Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285
Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events

Event DateEvent Description
Friday, June 11, 2021NEW APPLICATION ENTERED
Sunday, August 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 18, 2022ASSIGNED TO EXAMINER
Tuesday, January 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, February 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 19, 2022SOU EXTENSION 1 FILED
Monday, September 19, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 15, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 30, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 30, 2022SOU EXTENSION 1 GRANTED
Saturday, October 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 15, 2023SOU EXTENSION 2 FILED
Wednesday, March 15, 2023SOU EXTENSION 2 GRANTED
Monday, September 18, 2023SOU EXTENSION 3 FILED
Friday, March 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 18, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 18, 2023SOU EXTENSION 3 GRANTED
Thursday, March 14, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 14, 2024SOU EXTENSION 4 FILED
Wednesday, September 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 14, 2024SOU EXTENSION 4 GRANTED
Friday, March 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 5, 2024USE AMENDMENT FILED
Monday, August 5, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, August 7, 2024STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

kisunla disorders diseases pharmaceutical preparations dementia neurodegenerative neurological mental nervous treatment